首页> 外文OA文献 >Genome-Wide and Differential Proteomic Analysis of Hepatitis B Virus and Aflatoxin B1 Related Hepatocellular Carcinoma in Guangxi, China
【2h】

Genome-Wide and Differential Proteomic Analysis of Hepatitis B Virus and Aflatoxin B1 Related Hepatocellular Carcinoma in Guangxi, China

机译:广西乙型肝炎病毒和黄曲霉毒素B1相关肝细胞癌的全基因组和差异蛋白质组学分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Both hepatitis B virus (HBV) and aflatoxin B1 (AFB1) exposure can cause liver damage as well as increase the probability of hepatocellular carcinoma (HCC). To investigate the underlying genetic changes that may influence development of HCC associated with HBV infection and AFB1 exposure, HCC patients were subdivided into 4 groups depending upon HBV and AFB1 exposure status: (HBV(+)/AFB1(+), HBV(+)/AFB1(-), HBV(-)/AFB1(+), HBV(-)/AFB1(-)). Genetic abnormalities and protein expression profiles were analyzed by array-based comparative genomic hybridization and isobaric tagging for quantitation. A total of 573 chromosomal aberrations (CNAs) including 184 increased and 389 decreased were detected in our study population. Twenty-five recurrently altered regions (RARs; chromosomal alterations observed in ≥10 patients) in chromosomes were identified. Loss of 4q13.3-q35.2, 13q12.1-q21.2 and gain of 7q11.2-q35 were observed with a higher frequency in the HBV(+)/AFB1(+), HBV(+)/AFB1(-) and HBV(-)/AFB1(+) groups compared to the HBV(-)/AFB(-) group. Loss of 8p12-p23.2 was associated with high TNM stage tumors (P = 0.038) and was an unfavorable prognostic factor for tumor-free survival (P=0.045). A total of 133 differentially expressed proteins were identified in iTRAQ proteomics analysis, 69 (51.8%) of which mapped within identified RARs. The most common biological processes affected by HBV and AFB1 status in HCC tumorigenesis were detoxification and drug metabolism pathways, antigen processing and anti-apoptosis pathways. Expression of AKR1B10 was increased significantly in the HBV(+)/AFB1(+) and HBV(-)/AFB1(+) groups. A significant correlation between the expression of AKR1B10 mRNA and protein levels as well as AKR1B10 copy number was observed, which suggest that AKR1B10 may play a role in AFB1-related hepatocarcinogenesis. In summary, a number of genetic and gene expression alterations were found to be associated with HBV and AFB1- related HCC. The possible synergistic effects of HBV and AFB1 in hepatocarcinogenesis warrant further investigations.
机译:乙型肝炎病毒(HBV)和黄曲霉毒素B1(AFB1)暴露都可能引起肝损伤,并增加肝细胞癌(HCC)的可能性。为了研究可能影响与HBV感染和AFB1暴露相关的HCC发生的潜在遗传变化,根据HBV和AFB1暴露状态将HCC患者分为4组:(HBV(+)/ AFB1(+),HBV(+) / AFB1(-),HBV(-)/ AFB1(+),HBV(-)/ AFB1(-))。遗传异常和蛋白质表达谱通过基于阵列的比较基因组杂交和同量异位标记进行定量分析。在我们的研究人群中共检测到573个染色体畸变(CNA),包括184个增加和389个减少。鉴定了染色体中的二十五个重复改变区域(RAR;在≥10位患者中观察到的染色体改变)。 HBV(+)/ AFB1(+),HBV(+)/ AFB1(4)出现较高频率的4q13.3-q35.2、13q12.1-q21.2损失和7q11.2-q35的增益。 -)和HBV(-)/ AFB1(+)组与HBV(-)/ AFB(-)组相比。 8p12-p23.2的丢失与高TNM分期肿瘤相关(P = 0.038),并且是无肿瘤生存的不利预后因素(P = 0.045)。在iTRAQ蛋白质组学分析中共鉴定出133个差异表达蛋白,其中69个(51.8%)位于已鉴定的RARs中。在HCC肿瘤发生过程中,受HBV和AFB1状态影响的最常见生物学过程是排毒和药​​物代谢途径,抗原加工和抗凋亡途径。在HBV(+)/ AFB1(+)和HBV(-)/ AFB1(+)组中,AKR1B10的表达显着增加。观察到AKR1B10 mRNA的表达与蛋白质水平以及AKR1B10拷贝数之间的显着相关性,这表明AKR1B10可能在AFB1相关的肝癌发生中起作用。总之,发现许多遗传和基因表达改变与HBV和AFB1相关的HCC有关。 HBV和AFB1在肝癌发生中可能的协同作用值得进一步研究。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号